Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wirth

Showing results (601-610 of 675) with videos related to

Pageof 68
Sort By:
Medrxiv : the Preprint Server for Health Sciences|September 24, 2024
Immune Cell Densities Predict Response to Immune Checkpoint-Blockade in Head and Neck CancerDaniel A Ruiz-Torres, Michael E Bryan, Shun Hirayama, et al.
The Journal of Molecular Diagnostics : JMD|December 4, 2015
Detection of Circulating BRAF(V600E) in Patients with Papillary Thyroid CarcinomaCarrie C Lubitz, Sareh Parangi, Tammy M Holm, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 4, 2013
Bowman birk inhibitor concentrate and oral leukoplakia: a randomized phase IIb trialWilliam B Armstrong, Thomas H Taylor, Ann R Kennedy, et al.
Frontiers in Endocrinology|October 2, 2019
Analytical and Clinical Validation of Expressed Variants and Fusions From the Whole Transcriptome of Thyroid FNA SamplesTrevor E Angell, Lori J Wirth, Maria E Cabanillas, et al.
Biochemistry|March 26, 2020
Fluorescent Probes for Monitoring Serine UbiquitinationKedar Puvar, Aya M Saleh, Ryan W Curtis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2014
Phase I dose-escalation trial of the oral investigational Hedgehog signaling pathway inhibitor TAK-441 in patients with advanced solid tumorsJonathan Goldman, S Gail Eckhardt, Mitesh J Borad, et al.
Oncoimmunology|February 18, 2025
Spatial characterization of tertiary lymphoid structures as predictive biomarkers for immune checkpoint blockade in head and neck squamous cell carcinomaDaniel A Ruiz-Torres, Michael E Bryan, Shun Hirayama, et al.
Endocrine-Related Cancer|June 3, 2024
Vandetanib in locally advanced or metastatic differentiated thyroid cancer refractory to radioiodine therapyMarcia S Brose, Jaume Capdevila, Rossella Elisei, et al.
Headache|March 11, 2023
Patient-reported experiences with migraine-related cognitive symptoms: Results of the MiCOAS qualitative studyMaya T Gerstein, R J Wirth, Alyssa A Uzumcu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Induction docetaxel and carboplatin followed by weekly docetaxel and carboplatin with concurrent radiotherapy, then surgery in stage III non-small cell lung cancer: a Phase I studyLori J Wirth, Joan Lucca, Patricia Ostler, et al.
Pageof 68

Showing results (601-610 of 675) with videos related to

Sort By:
Pageof 68
Medrxiv : the Preprint Server for Health Sciences|September 24, 2024
Immune Cell Densities Predict Response to Immune Checkpoint-Blockade in Head and Neck CancerDaniel A Ruiz-Torres, Michael E Bryan, Shun Hirayama, et al.
The Journal of Molecular Diagnostics : JMD|December 4, 2015
Detection of Circulating BRAF(V600E) in Patients with Papillary Thyroid CarcinomaCarrie C Lubitz, Sareh Parangi, Tammy M Holm, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 4, 2013
Bowman birk inhibitor concentrate and oral leukoplakia: a randomized phase IIb trialWilliam B Armstrong, Thomas H Taylor, Ann R Kennedy, et al.
Frontiers in Endocrinology|October 2, 2019
Analytical and Clinical Validation of Expressed Variants and Fusions From the Whole Transcriptome of Thyroid FNA SamplesTrevor E Angell, Lori J Wirth, Maria E Cabanillas, et al.
Biochemistry|March 26, 2020
Fluorescent Probes for Monitoring Serine UbiquitinationKedar Puvar, Aya M Saleh, Ryan W Curtis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2014
Phase I dose-escalation trial of the oral investigational Hedgehog signaling pathway inhibitor TAK-441 in patients with advanced solid tumorsJonathan Goldman, S Gail Eckhardt, Mitesh J Borad, et al.
Oncoimmunology|February 18, 2025
Spatial characterization of tertiary lymphoid structures as predictive biomarkers for immune checkpoint blockade in head and neck squamous cell carcinomaDaniel A Ruiz-Torres, Michael E Bryan, Shun Hirayama, et al.
Endocrine-Related Cancer|June 3, 2024
Vandetanib in locally advanced or metastatic differentiated thyroid cancer refractory to radioiodine therapyMarcia S Brose, Jaume Capdevila, Rossella Elisei, et al.
Headache|March 11, 2023
Patient-reported experiences with migraine-related cognitive symptoms: Results of the MiCOAS qualitative studyMaya T Gerstein, R J Wirth, Alyssa A Uzumcu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Induction docetaxel and carboplatin followed by weekly docetaxel and carboplatin with concurrent radiotherapy, then surgery in stage III non-small cell lung cancer: a Phase I studyLori J Wirth, Joan Lucca, Patricia Ostler, et al.
Pageof 68